Of note, the lack of clinical and laboratory information (bone erosions, rheumatoid nodules, autoantibodies such as anti-CCPs, rheumatoid factor) as well as the absence of mRNA or protein expression studies to correlate with the four BLK and BANK1 variants studied, are some limitations of our study. The gene discussed is BLK; the disease is rheumatoid arthritis.